NCT00595556View on ClinicalTrials.gov

Zonisamide vs. Placebo in the Treatment of Alcohol Dependence

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
AlcoholismAlcohol AbuseAlcohol Dependence
Interventions
DRUG

zonisamide

flexible dosages of 100-500mg/day

DRUG

Placebo

Placebo

Trial Locations (1)

06030

University of Connecticut Health Center, Farmington

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

collaborator

National Center for Research Resources (NCRR)

NIH

lead

UConn Health

OTHER

NCT00595556 - Zonisamide vs. Placebo in the Treatment of Alcohol Dependence | Biotech Hunter | Biotech Hunter